The effect of cationic starch on hemoglobin, and the primary attempt to encapsulate hemoglobin
- 6 March 2015
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 43 (3) , 196-202
Abstract
Though starch has been a common material used for drug delivery, it has not been used as an encapsulation material for hemoglobin-based oxygen carriers. In this study, cationic amylose (CA) was synthesized by an etherification reaction. The interaction behaviors between CA and hemoglobin (Hb) were measured by zeta potential, size, and UV-Vis absorption spectra at different pH values. Cationic starch encapsulated Hb by electrostatic adhesion, reverse micelles, and cross-linking, and showed a core shell structure with a size of around 100 nm, when measured immediately after dispersing in PBS solution. However, we found that it was prone to swell, aggregate, and leak Hb with a longer duration of dispersal in PBS.Keywords
This publication has 14 references indexed in Scilit:
- A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volumeArtificial Cells, Nanomedicine, and Biotechnology, 2014
- Novel Nanodimension artificial red blood cells that act as O 2 and CO 2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydraseArtificial Cells, Nanomedicine, and Biotechnology, 2013
- Cationic amylose-encapsulated bovine hemoglobin as a nanosized oxygen carrierBiomaterials, 2011
- Polyhemoglobin-superoxide Dismutase-catalase-carbonic Anhydrase: A Novel Biotechnology-based Blood Substitute that Transports Both Oxygen and Carbon Dioxide and Also Acts as an AntioxidantArtificial Cells, Blood Substitutes, and Biotechnology, 2011
- Interaction behaviors between chitosan and hemoglobinInternational Journal of Biological Macromolecules, 2008
- Artificial Cells2007
- Controlled Delivery of Peptides and ProteinsCurrent Pharmaceutical Design, 2007
- Effects of polyhemoglobin-antioxidant enzyme complex on ischemia-reperfusion in kidneyTransplantation Proceedings, 2004
- Effect of artificial cells on hepatic function after ischemia–reperfusion injury in liverTransplantation Proceedings, 2004
- Reduction of Hydroxyl Radical Generation in a Rat Hindlimb Model of Ischemia-Reperfusion Injury Using Crosslinked Hemoglobin-Superoxide Dismutase-CatalaseArtificial Cells, Blood Substitutes, and Biotechnology, 1997